Open access
Technical Papers
Nov 21, 2019

Viral Surrogates in Potable Reuse Applications: Evaluation of a Membrane Bioreactor and Full Advanced Treatment

Publication: Journal of Environmental Engineering
Volume 146, Issue 2

Abstract

This study employed quantitative polymerase chain reaction (qPCR) to evaluate the occurrence and removal of five microbial surrogates at two water reuse facilities. The surrogates were (1) the 16S rRNA gene; (2) the AllBac assay for Bacteroides; (3) the Bacteroides bacteriophage ϕB124-14; (4) the Bacteroides bacteriophage ϕcrAssphage; and (5) the pepper mild mottle virus (PMMoV). Log removal values (LRVs) were quantified for a membrane bioreactor (MBR) and across a full advanced treatment (FAT) train. PMMoV, ϕB124-14, and ϕcrAssphage were detected in the MBR feed at concentrations of approximately 103  gene  copies(gc)/mL, 105  gc/mL, and 106  gc/mL, respectively. Only PMMoV was above the limit of quantification (LoQ) in the MBR filtrate (25±8  gc/mL), resulting in a wide range of viral LRVs: 1.4±0.5 for PMMoV, >3.9±0.3 for ϕB124-14, and >6.2±0.3 for ϕcrAssphage. All molecular targets were above the LoQ in the biologically treated FAT feed, but only the bacterial 16S rRNA gene was >LoQ after ozonation and biological activated carbon (BAC) and in the reverse osmosis (RO) concentrate. The gene was <LoQ in the RO permeate and after the UV advanced oxidation process (AOP).

Introduction

Fresh water supplies are diminishing as a result of human population growth and the impacts of climate change, greater urbanization, and increased water demands. These effects are sometimes exacerbated by competition across the municipal, industrial, agricultural, and environmental sectors (Kummu et al. 2010; Oki and Kanae 2006; Vörösmarty et al. 2000). Water reuse offers a viable strategy to alleviate this pressure, either by reducing environmental withdrawals, augmenting fresh water supplies, or directly supplying finished drinking water. This is accomplished with conventional or advanced treatment trains that can be optimized based on local wastewater characteristics to achieve a water quality consistent with the intended use (i.e., fit-for-purpose) and regulatory framework (Gerrity et al. 2013). Benchmark examples include the full advanced treatment (FAT) train employed by the Orange County Water District in California and the ozone-biofiltration treatment train employed by Gwinnett County, Georgia (Fig. 1). Although these treatment trains are able to remove a wide range of chemical and microbial contaminants (Pecson et al. 2015), there are potential risks that must be assessed and mitigated (Dominguez-Chicas and Scrimshaw 2010). For example, intermittent failures may increase microbial and/or chemical loads to downstream barriers (Pecson et al. 2018), potentially leading to compound failures (i.e., domino effects) and increased public health risks (Amoueyan et al. 2017, 2019).
Fig. 1. Indirect potable reuse treatment trains currently operating at (a and b) full-scale; and (c) demonstration-scale. Treatment train (c) also represents the treatment train at the potable reuse study site. Treatment trains (d) and (e) represent hypothetical alternatives employing membrane bioreactors instead of independent secondary/tertiary treatment and low-pressure membrane filtration systems. Treatment train (e) is shown with a UV advanced oxidation process because it is considered a more robust alternative for microbial inactivation and N-nitrosodimethylamine (NDMA) photolysis in potable reuse applications.
Regulatory frameworks currently rely on log removal values (LRVs) to estimate pathogen attenuation during treatment. Specifically, each qualifying unit process within a treatment train (e.g., ozonation, filtration, etc.) is awarded an LRV for each target pathogen (Sano et al. 2016; SWRCB 2016; Amarasiri et al. 2017). The sum of the LRVs across the whole treatment train is then calculated for each pathogen and compared against regulatory requirements or public health benchmarks (e.g., 104 annual risk of infection). These water reuse regulations are administered on a state-by-state basis in the United States (USEPA 2012), but there is currently little standardization across states or between countries (EPHC 2008; USEPA 2012; Paranychianakis et al. 2015; WHO 2017). For example, LRVs of 12/10/10 for viruses, Cryptosporidium, and Giardia are required for potable reuse in California, while North Carolina is considering LRVs of 6/5/4 for E. coli, MS2 bacteriophage, and Clostridium perfringens (USEPA 2012). These frameworks use raw sewage as the starting point for the LRV calculation. In contrast, Texas requires LRVs of 8/5.5/6 for viruses, Cryptosporidium, and Giardia, with conventional wastewater treatment plant effluent as the starting point for the LRV calculation (TWDB 2015). The LRV awarded for a particular unit process may even vary by facility within the same jurisdiction (SWRCB 2016).
One of the principal treatment processes affecting water quality and operational performance in water reuse applications is secondary biological treatment. This has traditionally been accomplished with activated sludge basins and secondary clarifiers, with low-pressure membranes often applied downstream of secondary treatment (Gerrity et al. 2013). Concurrent with the expansion of water reuse applications, the use of membrane bioreactors (MBRs) integrating biological treatment with semipermeable membranes has rapidly increased in popularity due to their reduced structural footprint and potential for improved water quality (Zhang and Farahbakhsh 2007; De Luca et al. 2013; Purnell et al. 2016). MBRs have been shown to remove microorganisms more effectively than conventional secondary treatment (De Luca et al. 2013; Francy et al. 2012; Hmaied et al. 2015; Ottoson et al. 2006), making them well suited for water reuse applications where human exposure is anticipated (Hai et al. 2014).
Despite their efficacy, MBRs are rarely awarded pathogen LRVs, while independent microfiltration (MF) or ultrafiltration (UF) membranes are generally awarded 0/4/4 LRVs for viruses, Cryptosporidium, and Giardia (SWRCB 2016). The resulting LRV deficiencies are problematic for potable reuse systems seeking to substitute an MBR for independent secondary and tertiary wastewater treatment processes (Fig. 1). In MBRs, larger microorganisms such as protozoa and bacteria should be retained by size exclusion, considering that nominal membrane pore sizes are often 0.1  μm (i.e., MF) or smaller (i.e., UF). Based on size alone, many bacteriophages and human viruses should pass through these membranes. However, studies have shown that MBRs can achieve high virus removal (Chaudhry et al. 2015; Kuo et al. 2010; Simmons et al. 2011), either due to inactivation during biological treatment (Bertucci et al. 1977; Ward 1982; Kim and Unno 1996) or physical removal facilitated by particle attachment (Van den Akker et al. 2014; Miura et al. 2015), cake or fouling layer development (Ueda and Horan 2000; Farahbakhsh and Smith 2004; Marti et al. 2011), or direct membrane interactions (Chaudhry et al. 2015; Lv et al. 2006; Wu et al. 2010). Cake layer disruption following membrane backwashing or cleaning may promote viral passage, but the degree of passage will depend on the pathogen, membrane pore size, and operational parameters (Hirani et al. 2014; Lv et al. 2006; Van den Akker et al. 2014; Erdal and Vorheis 2015).
From a design perspective, discrepancies between observed versus regulatory LRVs can result in overly conservative and potentially unsustainable treatment train designs (Schimmoller et al. 2015). Therefore, the water reuse industry is now considering virus LRVs for membrane-based processes, particularly for MBRs, and to identify rapid methods for validating process integrity and performance. This is often hindered by low ambient virus concentrations in membrane feeds, which necessitates spiking of surrogate viruses (e.g., MS2 bacteriophage) during challenge tests. However, alternative viral surrogates may occur in sufficient quantities under ambient conditions to facilitate characterization of membrane performance. These surrogates include plant viruses found in certain foods [e.g., pepper mild mottle virus (PMMoV)] and bacteriophages associated with nonpathogenic human gut microbiota (e.g., ϕcrAssphage and ϕB124-14). PMMoV is a rod-shaped (18×312  nm; Wetter et al. 1984) RNA virus with a low isoelectric point (3.2–4.9; Haramoto et al. 2013; Shirasaki et al. 2017). It is also one of the most abundant viruses in human feces (up to 109 virions per gram of dry feces; Zhang et al. 2006), presumably due to consumption of pepper-based foods. Consequently, PMMoV is abundant in wastewater (Rosario et al. 2009) and in drinking water sources (Haramoto et al. 2013). The Bacteroides-specific bacteriophages are spherical, double-stranded DNA viruses (Jofre et al. 2014; Stachler et al. 2017) with diameters of approximately 50 nm for ϕB124-14 (Ogilvie et al. 2012) and 75 nm for ϕcrAssphage (Shkoporov et al. 2018), with isoelectric points potentially similar to that of MS2 (pI=3.9; Rhodes et al. 2016). These bacteriophages have been found at high concentrations in wastewater: up to 106  gc/mL for ϕcrAssphage and up to 102 plaque forming units (PFU)/mL for ϕB124-14 (Jofre et al. 2014; Stachler and Bibby 2014). Because PMMoV, ϕB124-14, and ϕcrAssphage are abundant in feces—and ultimately raw sewage—they can serve as indicators of fecal contamination and as valuable surrogates for treatment process performance in water reuse applications.
In this study, we used quantitative polymerase chain reaction (qPCR) to monitor these endogenous viral surrogates and their bacterial analogues at a full-scale MBR facility and at a demonstration-scale FAT facility. The objectives of this study were to (1) quantify the occurrence of the five molecular targets in wastewater matrices; (2) characterize their removal across common unit processes in water reuse applications; and (3) determine their suitability for awarding virus LRVs (e.g., across an MBR).

Methods

Sample Collection

Samples were collected from two different water reuse study sites: (1) a full-scale MBR facility that produces an average of 15,000  m3/d of recycled water for nonagricultural irrigation in southern Nevada; and (2) a demonstration-scale potable reuse system that produces an average of 4,000  m3/d of water in southern California. The MBR facility treats primarily domestic wastewater for nonpotable reuse with coarse screening, grit chambers, fine screening, an MBR, and final disinfection with sodium hypochlorite (Fig. S1). Following a recent virus monitoring study (Erdal and Vorheis 2015), the facility received a waiver to maintain its existing UV disinfection system in standby mode. The MBR is operated at a solids retention time (SRT) of 8–10 days with full nitrification and partial denitrification. Solids separation is achieved with a UF membrane with a nominal pore size of 0.04 μm. Additional operational and performance details (e.g., water quality data) related to the MBR are summarized in Table S1 and Bacaro et al. (2019). For the current work, duplicate 10-liter samples of MBR feed (raw wastewater after screening and grit removal) and MBR filtrate (prior to chlorine disinfection) were collected in precleaned Nalgene carboys in April (2 feed and 2 filtrate samples) and June (2 feed and 2 filtrate samples) of 2018, as summarized in Table S2. The samples were immediately transported to the laboratory for concentration with hollow-fiber ultrafiltration (HFUF). HFUF concentrates were stored at 4°C overnight until further processing.
The demonstration-scale potable reuse system in southern California receives tertiary effluent from an adjacent full-scale treatment facility. The full-scale facility receives up to 114,000  m3/d of primarily domestic wastewater that is treated with activated sludge with biological nutrient removal, secondary clarification, anthracite media filtration, and chlorination/dechlorination. The demonstration-scale facility receives the tertiary effluent prior to disinfection and further treats it with ozone (O3/TOC=0.93 and CT=1.5  mg-min/L on sample collection day), biological activated carbon (BAC) with an empty bed contact time (EBCT) of 15 min, ultrafiltration, reverse osmosis (RO), and a UV advanced oxidation process (UV AOP) (Fig. S2). The RO-AOP combination qualifies as full advanced treatment in California, which allows for indirect potable reuse (IPR) via groundwater or surface water augmentation. Additional operational and performance details related to this demonstration-scale facility are summarized in Table S1 and Tackaert et al. (2019). Duplicate 10-liter samples of the FAT feed and the effluent from each treatment process (including RO permeate and RO concentrate) were collected during a single sample event in July of 2018, as summarized in Table S3. The samples were concentrated onsite to <1  L with HFUF and immediately stored on ice for transport to the laboratory.

Sample Concentration

Each 10-liter sample was concentrated using a HFUF setup adapted from Hill et al. (2005) (Fig. 2 and Table 1). Briefly, MBR feed samples were prefiltered with 100-μm particle retention filter paper (Whatman grade 0965) to prevent clogging during HFUF, removing 2  g of wet solids per sample. The solids were stored at 20°C and later processed for molecular analyses, and the filtrates were returned to Nalgene carboys for HFUF. Immediately prior to HFUF, each REXEED-25S ultrafilter (29 kDa) was blocked by recirculating 250 mL of 0.01% sodium polyphosphate (NaPP) for 3 min using a Masterflex L/S Easy Load II peristaltic pump (Model 77200-62) and sterile silicone tubing (L/S 24). Samples were also amended with 0.01% NaPP for particle dispersion (Hill et al. 2005). Ultrafiltration was performed by recirculation at 1,500  mL/min, yielding an average of 240±23  mL of retentate per 10-L sample. Retentates were immediately stored at 4°C. Residual particulates in the REXEED filter and tubing were eluted by recirculating 300 mL of an elution solution (0.01% Tween 80, 0.01% NaPP, 0.001% Antifoam Y30) for 5 min, yielding an average volume of 427±58  mL of eluate. Retentates and eluates were then combined to yield an average volume of 666±69  mL of concentrate per 10-L sample (Table 1). HFUF concentrates (20–50 mL) were processed with Centricon Plus-70 Centrifugal Filter Devices (30 kDa) in triplicate. The resulting concentrates (1  mL each) were stored at 20°C prior to nucleic acid extraction. This sample concentration procedure resulted in an equivalent sample volume of 10  mL for each 10-L sample (Table 1).
Fig. 2. Schematic of (a) the HFUF setup; and (b) sample concentration and analysis, including HFUF, Centricon filter concentration, and nucleic acid extraction. This procedure resulted in equivalent sample volumes of 3–15 mL from the original 10-L samples.
Table 1. Summary of average sample volumes of experimental and analytical replicates at each sample processing stage
SampleHFUF concentrate volume (mL)Centricon filter (CF) sample volume (mL)CF concentrate volume (mL)CF concentrate extracted (mL)DNA extract volume (μL)qPCR assay (μL)Equivalent sample volume (mL)
MBR feed672±3523±21±00.355012.66±1.04
MBR filtrate712±4343±70.8±0.20.355015.33±1.45
FAT feed625±550±00.70±0.080.355017.72±0.94
O3668±5750±00.58±0.140.355019.47±1.60
BAC635±550±00.50±0.020.3550111.42±0.47
UF587±8050±00.42±0.070.3550114.31±2.83
RO795±1150±00.55±0.080.355018.20±1.23
Brine600±5550±00.98±0.200.355016.15±1.20
UV AOP645±1450±00.55±0.060.355019.92±0.90

Note: Data represent averages ±1 standard deviation. The starting volume for all samples was 10 L.

Nucleic Acid Extraction and Analysis

DNA and RNA were extracted from 350-μL Centricon concentrates or from 0.2 g of solids obtained during the prefiltration step for the MBR feed using the PureLink™ Viral RNA/DNA Mini Kit. DNA was quantified with a Qubit 3.0 Fluorometer and a dsDNA HS Assay kit.
Complementary DNA (cDNA) was synthetized from neat or 10-fold diluted DNA/RNA extracts using an iScript™ Select cDNA Synthesis Kit. Reactions were carried out in a gradient cycler in 20-μL volumes containing 5 μL of template, 8 μL of water, 4 μL of 5X iScript select reaction mix (1X final concentration), 2 μL of 50 μM random primer (5 μM final concentration), and 1 μL of iScript reverse transcriptase. Reactions were incubated at 25°C for 5 min, 42°C for 30 min, and 85°C for 5 min and then held at 4°C.
Nucleic acids were analyzed for the presence of five qPCR targets (Table 2). The 16S rRNA gene assay (V1/V2 region) quantified all bacteria, the AllBac assay quantified bacteria belonging to the genus Bacteroides, the B124-14 and crAssphage assays quantified Bacteroides-specific bacteriophages (ϕB124-14 and ϕcrAssphage), and the PMMoV assay quantified the pepper mild mottle virus. These targets are emerging viral surrogates (or their bacterial analogues) relevant for water reuse applications. Human pathogens and other common bacteriophages were omitted from this study because they were not detected (e.g., enterovirus, hepatitis A, rotavirus, and poliovirus) or detected at relatively low concentrations (e.g., adenovirus, norovirus GI and GII, MS2, and somatic coliphage) in a previous virus monitoring study at the same MBR facility (Erdal and Vorheis 2015).
Table 2. Summary of the qPCR assays used in this study
AssayTargetPrimer nameSequence (5′ → 3′)Annealing Temp. (°C)Reference
16S rRNA gene16S rRNA gene of28FGAGTTTGATCNTGGCTCAG60Gerrity et al. (2018)
bacteria (V1/V2)388RTGCTGCCTCCCGTAGGAGT
AllBacBacteroidesAllBac296FGAGAGGAAGGTCCCCCAC57Reischer et al. (2013)
genusAllBac412RCGCTACTTGGCTGGTTCAG
B124-14BacteroidesB124-14_FTTTTGCAGCAACACGCCTAC55Current study
ϕB124-14B124-14_RGGTGCGGGACTTACCTTTGA
crAssphageBacteroidesCP_064_FTGTATAGATGCTGCTGCAACTGTACTC60Stachler et al. (2018)
ϕcrAssphageCP_064_RCGTTGTTTTCATCTTTATCTTGTCCAT
PMMoVPepper Mild MottlePMMoV_FGTGGCAGCAAAGGTAATGGT55Hamza et al. (2011)
Virus (PMMoV)PMMoV_RATTTGCTTCGGTAGGCCTCT
For the qPCR assays, primers and standards were purchased from Integrated DNA Technologies (Coralville, Iowa). Standards were resuspended in 1X TE (10  mMTris/0.1  mM  EDTA) buffer to 10  ng/μL and quantified with Qubit 3.0 and the dsDNA HS Assay kit. A 108  gc/μL stock was made for each standard by diluting the purchased stock in an appropriate volume of 1X TE. Volumes were calculated using a DNA Copy Number and Dilution Calculator (ThermoFisher Scientific, Waltham, Massachusetts). Tenfold serial dilutions were made from each 108  gc/μL stock to generate standard curves ranging from 108 to 100  gc/μL (example standard curves are shown in Fig. S3). Triplicate 10-μL qPCR reactions contained 1 μL of neat or 10-fold diluted template, 3.6 μL of nuclease-free water, 5.0 μL of 2X iTaq Universal SYBR Green Supermix (1X final concentration), and 0.2 μL of each 20-μM primer (0.4 μM final concentration). Assays were run on a CFX96 Touch™ Real-Time PCR Detection System set to 95°C for 2 min for initial denaturation and 39 cycles of denaturation at 95°C for 5 s, annealing at the assay-specific temperature (Table 2) for 30 s, and extension at 72°C for 30 s. The protocol concluded with a melt curve from 65°C to 90°C in increments of 0.5°C for 5 s and a final plate read. Assay efficiencies were >98% for all targets.

Quality Assurance/Quality Control

For each assay, the limit of quantification (LoQ) was determined by analyzing a set of known test samples (1,000 to 1  gc/μL of template) and controls [no template control (NTC) and a blank] using a t-test. First, the method detection limit (MDL) for each assay was determined by examining dilution linearity, consistent amplification, and melt curve characteristics. Dilutions that failed to meet these requirements (i.e., <MDL) were omitted from the standard curves (Fig. S3). The test samples (six replicates) were prepared at the MDL concentration using IDT standards and analyzed by qPCR. The LoQs (gc/μL of template) were calculated using two different approaches: (1) a one-sided t-test with 99% confidence [Eq. (1)], as recommended by the US Environmental Protection Agency; and (2) a one-sided t-test with 95% confidence [Eq. (2)]. The more conservative USEPA approach was used for the 16S rRNA gene assay, while the alternative approach was used for the remaining molecular targets. The justification for use of the higher LoQ for the 16S rRNA gene was to mitigate the effects of false amplification, which can be common for 16S rRNA gene assays due to inherent DNA contamination of master mixes (Czurda et al. 2015; Mühl et al. 2010; Rand and Houck 1990; Rueckert and Morgan 2007; Salter et al. 2014; Spangler et al. 2009; Tondeur et al. 2004). The assay-specific LoQs are summarized in Table S4
LoQ=ts
(1)
where t = student’s t-test statistic (α=0.01 and n1 degrees of freedom); and s = standard deviation
LQ=ts/N
(2)
where t = student’s t-test statistic (α=0.05 and n1 degrees of freedom); s = standard deviation; and N = number of replicates.

Data Analysis

All qPCR data and sample amplification curves were generated and visually inspected with CFX96 software. For each assay, raw Cq values were compiled into a single document and converted to gc/μL of template DNA using a combined regression equation for each assay across all qPCR runs. Data were corrected for equivalent sample volumes (Table 1) to determine the corresponding concentrations in the original samples. LRVs were calculated using Eq. (3), with LoQs substituted for censored data
LRV=log10(Cinitial,i/Cfinal,i)
(3)
where Cinitial = concentration in the feed to treatment process i; and Cfinal = concentration in the effluent from treatment process i (or LoQ).
Gene copy data were log transformed and analyzed with a three-way ANOVA (for the MBR facility) or a two-way ANOVA (for the FAT facility) using SPSS statistical software. Normality assumption was assessed with the Shapiro-Wilk test, and assumption of homogeneity of variances was assessed with Levene’s test. Statistical significance was set at α=0.05 for all tests. LRV data were analyzed with a two-way mixed and a two-way ANOVA in SPSS 25 using nontransformed data.

Results and Discussion

Membrane Bioreactor Feed

This study builds upon a separate virus monitoring study previously conducted at the same MBR study site by a different research team (Erdal and Vorheis 2015); the corresponding data are summarized in Table S5. Their objective was to demonstrate the MBR’s efficacy in attenuating human pathogenic viruses and surrogate coliphages. Across five sample sets, the geometric mean concentrations for the MBR feed were 102  gc/mL for adenovirus and norovirus GI (detected in 3 of 5 samples), 101  gc/mL for norovirus GII (detected in 3 of 5 samples), and 101  PFU/mL for MS2 and somatic coliphage. Coliphages were often detected in MBR filtrate during high flux conditions or immediately after membrane cleaning, but human viruses were generally not detected in MBR filtrate under any operational condition. Considering all data (with LoQs substituted for nondetects), the corresponding LRVs were 4.9±1.6 for human pathogens and 3.0±0.6 for coliphages (p>0.50 within groups and p=0.045 between groups). Building upon these preliminary data, the current study aimed to determine whether the emerging surrogate viruses might allow for LRV quantification across a greater range (i.e., potentially greater abundance in the MBR feed) and with more precision (i.e., detection in both the MBR feed and filtrate).
In this study, concentrations of all molecular targets in the prefiltered solids from the MBR feed constituted a negligible fraction of the total (i.e., <0.1%). In contrast, the liquid fraction of the MBR feed contained high concentrations of the molecular targets, as illustrated in Fig. 3. The 16S rRNA gene averaged (1.16±0.25)×107  gc/mL in April 2018 and significantly increased to (4.14±2.15)×107  gc/mL in June 2018 (p<0.005). Members of the genus Bacteroides comprised a relatively large portion (85% and 30%) of the bacterial community in the MBR feed, with average concentrations of (9.81±2.61)×106  gc/mL in April and (1.25±0.69)×107  gc/mL in June (p=0.511). Bacteroides (and more generally the phylum Bacteroidetes) dominate the western human gut microbiota (Ley et al. 2006), hence their relative prominence in sewage should not be surprising. For comparison, Gerrity and Neyestani (2019) reported a lower, yet still significant, relative abundance of 7% for Bacteroides in a similar primary effluent; this value is roughly consistent with other surveys of human-derived bacteria in sewage (Fisher et al. 2015; Newton et al. 2015). The difference in relative abundance between these studies might be attributable to the slight difference in wastewater matrix or differences between semiquantitative methods (i.e., qPCR versus 16S rRNA gene sequencing). Nevertheless, these data demonstrate that genetic markers for Bacteroides, including their associated bacteriophages (Ogilvie et al. 2012; Stachler and Bibby 2014), are useful indicators of fecal contamination in environmental samples (Ahmed et al. 2008).
Fig. 3. Concentrations of microbial targets (gc/mL) in the MBR feeds (black) and filtrates (gray) collected in April (solid) or June (striped). The data indicate gene copies per mL of original sample. The < symbols indicate that the corresponding concentrations were below the limits of quantification designated by the column. Columns represent averages (±1 standard deviation) of experimental and analytical replicates after correcting for sample-specific equivalent sample volumes.
Bacteroides-specific ϕB124-14 was abundant in all MBR feed samples but at a significantly higher concentration in April (2.46±1.11)×105  gc/mL than in June (5.64±1.74)×104  gc/mL (p=0.003). There was a slight correlation between the abundance of the bacteriophage and its host in April (R2=0.60) but to a lesser extent in June (R2=0.36, Fig. S4). The relatively poor correlations might be explained by the inherently different characteristics of the bacterium and its phage, including size (Marti et al. 2011) and isoelectric point (Xagoraraki et al. 2014), which may have affected removal during preliminary treatment steps (i.e., screening or grit removal) or recovery efficiencies during sample concentration. For example, Enterococcus faecalis recovery was higher (93%±16%) than MS2 bacteriophage (57%±7.7%) for low turbidity water in Smith and Hill (2009).
The other Bacteroides phage, ϕcrAssphage, was also highly abundant in the MBR feed, with average concentrations of (1.47±1.87)×106  gc/mL in April and (7.31±2.40)×105  gc/mL in June, but there was no significant difference between the two sample events (p=0.290). This phage has been detected at relatively high numbers in other raw wastewater samples: 2.9×103  gc/ng of total DNA (Stachler et al. 2017), 7.9×106  gc/mL (García-Aljaro et al. 2017), and 7.1×106  gc/mL (Ahmed et al. 2018). Stachler et al. (2018) also reported a ϕcrAssphage concentration of 8.7×103  gc/mL in an urban stream impacted by combined sewer overflows. This virus was cultured only recently (Shkoporov et al. 2018), so its original identification (Dutilh et al. 2014) and subsequent monitoring efforts have generally relied upon molecular analyses.
In contrast with the bacteriophages but comparable to the pathogens in Erdal and Vorheis (2015), the plant virus, PMMoV, was detected at relatively low concentrations in the MBR feed, with an average of (1.96±0.37)×103  gc/mL in April and (3.10±2.16)×102  gc/mL in June (p=0.001). According to the literature, PMMoV concentrations vary considerably between studies and by water matrix: 103 to 107  gc/mL in raw wastewater (Symonds et al. 2018), <102 to 106  gc/mL in treated wastewater (Symonds et al. 2018), 101 to 103  gc/mL in surface water (Hamza et al. 2011; Kato et al. 2018), and 101  gc/mL in finished drinking water (Kato et al. 2018). PMMoV concentrations in this study appear low for raw wastewater, but the specific reason(s) for this discrepancy cannot be determined at this time.

Membrane Bioreactor Filtrate

MBR filtrate concentrations for the five molecular targets are shown in Fig. 3. The 16S rRNA gene averaged (1.68±0.34)×104  gc/mL in April and (8.80±2.07)×103  gc/mL in June (p=0.003). The Bacteroides-specific marker also amplified in all MBR filtrate samples but was below the LoQ. There are several possible explanations for detection of bacteria in MBR filtrate, which is unexpected given the small membrane pore size (0.04 μm). Bacterial detection could indicate colonization (e.g., biofilm growth) downstream of the MBR (DeCarolis and Adham 2007), which is more likely for environmental versus host-specific bacteria. This was supported by the abundance of the bacterial 16S rRNA gene in the MBR filtrate and the lack of Bacteroides, which thrive in the gastrointestinal tracts of their hosts and have low potential for growth in the environment (Ahmed et al. 2008; Layton et al. 2006). For this reason, Bacteroides (or other fecal indicators such as total coliform and E. coli) represent a more suitable surrogate than the more general 16S rRNA gene when evaluating membrane performance and integrity, particularly for an MBR that has significant upstream biological activity. Alternatively, the presence of extracellular DNA (eDNA), which can persist for a long time in the environment (Nielsen et al. 2007; Dlott et al. 2015) and is abundant in activated sludge systems (Dominiak et al. 2011), might also explain the detection of 16S rRNA genes and Bacteroides (albeit<LoQ) in the MBR filtrate.
Both Bacteroides bacteriophages were <LoQ in all MBR filtrate samples (Fig. 3). These data show that both phages were removed to the extent measurable by this method, consistent with other phage studies (Zanetti et al. 2010) and specifically for ϕB124-14 (Purnell et al. 2016); no other studies have evaluated ϕcrAssphage removal by MBR. In contrast, PMMoV was detected at quantifiable levels, with average concentrations of (2.58±0.44)×101  gc/mL in April and (2.37±1.05)×101  gc/mL in June (p=0.072). PMMoV has been detected at high concentrations in other MBR filtrates (Jumat et al. 2017), thereby indicating its potential to persist through activated sludge systems and pass through MF or UF membranes.

Membrane Bioreactor Log Removal Values

Table 3 summarizes the observed LRVs for the MBR. The LRVs for the 16S rRNA gene were 3.25±0.19 across both sampling events, but these values are not indicative of MBR performance given the potential for bacterial growth downstream of the MBR. The Bacteroides data are more consistent with expectations of a UF membrane, with LRVs of at least five for all samples (limited by the LoQ). ϕcrAssphage (LRV>6.15±0.28 across both sampling events) exhibited greater removal than ϕB124-14 (LRV>3.87±0.30 across both sampling events), but this was an artifact of ϕB124-14’s lower abundance in the MBR feed coupled with its higher LoQ. Interestingly, PMMoV exhibited considerably lower LRVs, with significant differences between April (1.88±0.14) and June (0.96±0.26) (p=0.023).
Table 3. Average log removal values across the MBR and FAT train based on experimental and analytical replicates
Microbial targetMBRFAT train
AprilJuneO3BACUFRO-UV AOP
Bacteria2.84±0.093.65±0.281.62±0.500.49±0.451.36±0.22>1.00±0.10
Bacteroides>5.36±0.10>5.61±0.24>1.91±0.23N/AN/AN/A
ϕB124-14>4.09±0.25>3.65±0.15>0.14±0.06N/AN/AN/A
ϕcrAssphage>6.14±0.38>6.16±0.19>2.95±0.25N/AN/AN/A
PMMoV1.88±0.140.96±0.26>2.91±0.37N/AN/AN/A

Note: Data represent averages ±1 standard deviation. Calculation of some LRVs was not possible due to analytical limitations; these LRVs were calculated based on the corresponding limits of quantification and are denoted by > symbols. N/A = not applicable due to analytical limitations for the preceding treatment step.

These LRV data are consistent with MBR literature. For example, Purnell et al. (2016) reported LRVs of >6 for enterococci and coliform bacteria and 4.0 for ϕB124-14, while Hamza et al. (2011) reported lower LRVs for PMMoV ranging from 1.7 to 3.7. Because PMMoV, ϕB124-14, and ϕcrAssphage are likely negatively charged in environmental systems, the observed differences in removal are most likely due to their differing morphologies (rod-shaped PMMoV versus spherical bacteriophages). To the best of our knowledge, no other data are available for ϕcrAssphage removal by MBRs, presumably due to its relatively recent discovery (Stachler and Bibby 2014) and even more recent establishment as an indicator of fecal contamination (Ahmed et al. 2018). In comparison with Erdal and Vorheis (2015), the ϕB124-14 and ϕcrAssphage data from this study are consistent with the LRVs for human pathogenic viruses (i.e., adenovirus and norovirus), while PMMoV data are closer to MS2 and somatic coliphage LRVs immediately following membrane cleaning (Table S5).
It is also important to differentiate LRVs calculated from MBR feed and MBR filtrate (this current study) versus MBR mixed liquor and MBR filtrate (Simmons et al. 2011). For the latter case, mixing of the MBR feed with concentrated return activated sludge (RAS) may result in higher concentrations of target microorganisms and higher LRVs. Simmons et al. (2011) reported average LRVs of 5.5, 5.1, and 3.9 for adenovirus, enterovirus, and norovirus GII, respectively, using MBR mixed liquor as the baseline, but the average LRVs decreased to approximately 3.1, 3.6, and 4.7 when using the MBR feed as the baseline. The lower LRVs observed in Simmons et al. (2011) suggest that ϕB124-14 might be a more suitable surrogate than ϕcrAssphage for virus removal by MBR, although ϕcrAssphage was more consistent with pathogen removal observed in Erdal and Vorheis (2015). Further, because of its unique morphology and exceptionally low LRVs, PMMoV may be an overly conservative surrogate when evaluating the performance of an MBR, or low pressure membranes generally.

Full Advanced Treatment Train

The FAT feed was a tertiary effluent (activated sludge, secondary clarification, and anthracite media filtration) from an adjacent full-scale wastewater treatment plant. The corresponding raw sewage and primary effluent were inaccessible at the time of sample collection so a direct comparison with the aforementioned MBR feed was not possible. The FAT feed is consequently more representative of the MBR filtrate, albeit without the effects of membrane filtration, which explains why its concentrations were generally lower than those of the MBR feed but higher than those of the MBR filtrate (Fig. 4): 16SrRNAgene=(2.79±1.40)×105  gc/mL; Bacteroides=(1.76±1.02)×103  gc/mL; ϕB124-14=(3.10±0.73)×101  gc/mL; ϕcrAssphage=(3.38±2.66)×102  gc/mL; and PMMoV=(8.69±7.69)×102  gc/mL. Interestingly, the PMMoV concentration in the FAT feed was comparable to that of the MBR feed (p=0.143), thereby suggesting minimal removal during standard secondary/tertiary wastewater treatment and/or higher raw sewage concentrations at the southern California site.
Fig. 4. Concentrations of microbial targets (gc/mL) across the full advanced treatment train. The data indicate gene copies per mL of original sample. The < symbols indicate that the corresponding concentrations were below the limits of quantification designated by the columns. Columns represent averages (±1 standard deviation) of experimental and analytical replicates after correcting for sample-specific equivalent sample volumes. All assays were < LoQ for the RO and UV AOP samples.
Low concentrations of the remaining surrogates limited our capability to calculate and demonstrate LRVs across the FAT train (Table 3). With the exception of the 16S rRNA gene, all of the molecular targets were <LoQ following ozonation. The corresponding LRVs for ozonation were 1.62±0.50 for the 16S rRNA gene, >1.91±0.23 for Bacteroides, >0.14±0.06 for ϕB124-14, >2.95±0.25 for ϕcrAssphage, and >2.91±0.37 for PMMoV. For comparison, an O3/TOC ratio of 1.0 is expected to achieve LRVs of at least 2, 5, and 6 for spore-forming bacteria, vegetative bacteria, and viruses, respectively (Gamage et al. 2013). There was a 0.5-log increase in 16S rRNA gene concentration following BAC, as might be expected of a biological process with potential for biomass sloughing (Howell and Atkinson 1976).
The UF process achieved an LRV of only 1.36±0.22 for the 16S rRNA gene, but again, this is not indicative of membrane performance/integrity because of the confounding factors associated with the 16S rRNA gene. In fact, the 16S rRNA gene was detected at similar levels across another FAT train in southern California (Stamps et al. 2018). Relative to UF filtrate, there was a three-fold increase in the concentration of the 16S rRNA gene in the RO concentrate, with all other targets <LoQ. Considering that RO processes are known to concentrate a variety of wastewater-derived contaminants (Alturki et al. 2010), the fact that no other molecular targets were detected in RO brine is either a testament to the upstream UF or the additional robustness provided by the O3-BAC processes that are not commonly included in FAT. Finally, all molecular targets were <LoQ in the RO permeate and UV AOP effluent.

Conclusions

Use of MBRs is increasing in water reuse applications, but broad implementation for potable reuse requires a regulatory framework for awarding LRVs. Such a framework requires extensive datasets, rapid methods, and suitable surrogates to document process performance and integrity with sufficient frequency. In this study, Bacteroides–associated ϕB124-14, ϕcrAssphage, and plant-associated PMMoV were highly abundant in the MBR feed, which allowed for demonstrating LRVs>6×logs for ϕcrAssphage. However, data in the literature suggest that the more conservative LRVs observed for ϕB124-14 (overall average LRV>3.9) may be more consistent with human pathogen removal by MBR. PMMoV proved to be a valuable indicator of human fecal contamination due to its persistence through wastewater treatment, but it may be an overly conservative surrogate for treatment performance (overall average LRV=1.4). Finally, FAT was effective in achieving the LoQs for all molecular targets, but surrogate abundance was insufficient to demonstrate LRVs beyond the initial ozone treatment process, at least with the methods used in this study. Although data provided here report a case study, this information expands our knowledge by increasing the existing body of scientific literature devoted to various aspects of water treatment and reuse. Yet, a more comprehensive study evaluating viral surrogates in multiple MBR and FAT facilities is warranted to characterize the broad applicability of the data presented here.

Supplemental Data

Figs. S1S4 and Tables S1S5 are available online in the ASCE library (www.ascelibrary.org).

Supplemental Materials

File (supplemental_data_ee.1943-7870.0001617_pappa.pdf)

Data Availability Statement

All data generated or used during this study are available from the corresponding author by request.

Acknowledgments

This research was supported by funding from the University of Nevada Las Vegas/Desert Research Institute (UNLV/DRI) Joint Postdoctoral Fellowship Program and a grant from the National Institute of General Medical Sciences (P20GM103440). The authors would also like to acknowledge Mitch Stoker, Willie Frehner, and Sal Huerta from the Southern Nevada Water Authority; Dr. Aleksey Pisarenko and Elise Chen from Trussell Technologies; Zhiyin Qin, Mayra Sarria, and Fernanda Bacaro from UNLV; and the two study sites for access to their facilities.

References

Ahmed, W., A. Lobos, J. Senkbeil, J. Peraud, J. Gallard, and V. J. Harwood. 2018. “Evaluation of the novel crAssphage marker for sewage pollution tracking in storm drain outfalls in Tampa, Florida.” Water Res. 131 (Mar): 142–150. https://doi.org/10.1016/j.watres.2017.12.011.
Ahmed, W., J. Stewart, D. Powell, and T. Gardner. 2008. “Evaluation of Bacteroides markers for the detection of human faecal pollution.” Lett. Appl. Microbiol. 46 (2): 237–242. https://doi.org/10.1111/j.1472-765X.2007.02287.x.
Alturki, A. A., N. Tadkaew, J. A. McDonald, S. J. Khan, W. E. Price, and L. D. Nghiem. 2010. “Combining MBR and NF/RO membrane filtration for the removal of trace organics in indirect potable water reuse applications.” J. Membr. Sci. 365 (1–2): 206–215. https://doi.org/10.1016/j.memsci.2010.09.008.
Amarasiri, M., M. Kitajima, T. H. Nguyen, S. Okabe, and D. Sano. 2017. “Bacteriophage removal efficiency as a validation and operational monitoring tool for virus reduction in wastewater reclamation: Review.” Water Res. 121 (Sep): 258–269. https://doi.org/10.1016/j.watres.2017.05.035.
Amoueyan, E., S. Ahmad, J. Eisenberg, and D. Gerrity. 2019. “Equivalency of indirect and direct potable reuse paradigms based on a quantitative microbial risk assessment framework.” Microb. Risk Anal. 12 (Aug): 60–75. https://doi.org/10.1016/j.mran.2019.06.003.
Amoueyan, E., S. Ahmad, J. Eisenberg, B. Pecson, and D. Gerrity. 2017. “Quantifying pathogen risks associated with potable reuse: A risk assessment case study for Cryptosporidium.” Water Res. 119 (Aug): 252–266. https://doi.org/10.1016/j.watres.2017.04.048.
Bacaro, F., E. Dickenson, R. A. Trenholm, and D. Gerrity. 2019. “N-Nitrosodimethylamine (NDMA) formation and mitigation in potable reuse treatment trains employing ozone and biofiltration.” Environ. Sci. Water Res. Technol. 5 (4): 713–725. https://doi.org/10.1039/C8EW00926K.
Bertucci, J. J., C. Lue-Hing, D. Zenz, and S. J. Sedita. 1977. “Inactivation of viruses during anaerobic sludge digestion.” J. Water Pollut. Control Fed. 49 (7): 1642–1651.
Chaudhry, R. M., K. L. Nelson, and J. E. Drewes. 2015. “Mechanisms of pathogenic virus removal in a full-scale membrane bioreactor.” Environ. Sci. Technol. 49 (5): 2815–2822. https://doi.org/10.1021/es505332n.
Czurda, S., S. Smelik, S. Preuner-Stix, F. Nogueira, and T. Lion. 2015. “Occurrence of fungal DNA contamination in PCR reagents: Approaches to control and decontamination.” J. Clin. Microbiol. 54 (1): 148–152. https://doi.org/10.1128/JCM.02112-15.
DeCarolis, J. F., and S. Adham. 2007. “Performance investigation of membrane bioreactor systems during municipal wastewater reclamation.” Water Environ. Res. 79 (13): 2536–2550. https://doi.org/10.2175/106143007X212184.
De Luca, G., R. Sacchetti, E. Leoni, and F. Zanetti. 2013. “Removal of indicator bacteriophages from municipal wastewater by a full-scale membrane bioreactor and a conventional activated sludge process: Implications to water reuse.” Bioresour. Technol. 129 (Feb): 526–531. https://doi.org/10.1016/j.biortech.2012.11.113.
Dlott, G., J. E. Maul, J. Buyer, and S. Yarwood. 2015. “Microbial rRNA: rDNA gene ratios may be unexpectedly low due to extracellular DNA preservation in soils.” J. Microbiol. Methods. 115 (Aug): 112–120. https://doi.org/10.1016/j.mimet.2015.05.027.
Dominguez-Chicas, A., and M. D. Scrimshaw. 2010. “Hazard and risk assessment for indirect potable reuse schemes: An approach for use in developing water safety plans.” Water Res. 44 (20): 6115–6123. https://doi.org/10.1016/j.watres.2010.07.007.
Dominiak, D. M., J. L. Nielsen, and P. H. Nielsen. 2011. “Extracellular DNA is abundant and important for microcolony strength in mixed microbial biofilms.” Environ. Microbiol. 13 (3): 710–721. https://doi.org/10.1111/j.1462-2920.2010.02375.x.
Dutilh, B. E., et al. 2014. “A highly abundant bacteriophage discovered in the unknown sequences of human faecal metagenomes.” Nat. Commun. 5 (Jul): 1–11. https://doi.org/10.1038/ncomms5498.
EPHC (Environmental Protection and Heritage Council). 2008. Australian guidelines for water recycling: Managing health and environmental risks (Phase 2): Augmentation of drinking water supplies. Canberra, Australia: EPHC.
Erdal, U., and J. Vorheis. 2015. “Can MBR eliminate additional disinfection? A case study.” In Proc., Annual Conf. of the Water Environment Association of Texas. Austin, TX: Water Environment Association of Texas.
Farahbakhsh, K., and D. W. Smith. 2004. “Removal of coliphages in secondary filtrate by microfiltration: Mechanisms of removal and impact of operating parameters.” Water Res. 38 (3): 585–592. https://doi.org/10.1016/j.watres.2003.10.018.
Fisher, J. C., A. M. Eren, H. C. Green, O. C. Shanks, H. G. Morrison, J. H. Vineis, M. L. Sogin, and S. L. McLellan. 2015. “Comparison of sewage and animal fecal microbiomes using oligotyping reveals potential human fecal indicators in multiple taxonomic groups.” Appl. Environ. Microbiol. 81 (20): 7023–7033. https://doi.org/10.1128/AEM.01524-15.
Francy, D. S., E. A. Stelzer, R. N. Bushon, A. M. G. Brady, A. G. Williston, K. R. Riddell, M. A. Borchardt, S. K. Spencer, and T. M. Gellner. 2012. “Comparative effectiveness of membrane bioreactors, conventional secondary treatment, and chlorine and UV disinfection to remove microorganisms from municipal wastewaters.” Water Res. 46 (13): 4164–4178. https://doi.org/10.1016/j.watres.2012.04.044.
Gamage, S., D. Gerrity, A. Pisarenko, E. C. Wert, and S. A. Snyder. 2013. “Evaluation of process control alternatives for the inactivation of Escherichia coli, MS2 bacteriophage, and Bacillus subtilis spores during wastewater ozonation.” Ozone Sci. Eng. 35 (6): 501–513. https://doi.org/10.1080/01919512.2013.833852.
García-Aljaro, C., E. Ballesté, M. Muniesa, and J. Jofre. 2017. “Determination of crAssphage in water samples and applicability for tracking human faecal pollution.” Microb. Biotechnol. 10 (6): 1775–1780. https://doi.org/10.1111/1751-7915.12841.
Gerrity, D., M. Arnold, E. Dickenson, D. Moser, J. D. Sackett, and E. C. Wert. 2018. “Microbial community characterization of ozone-biofiltration systems in drinking water and potable reuse applications.” Water Res. 135 (May): 207–219. https://doi.org/10.1016/j.watres.2018.02.023.
Gerrity, D., and M. Neyestani. 2019. “Impacts of solids retention time and antibiotic loading in activated sludge systems on secondary effluent water quality and microbial community structure.” Water Environ. Res. 91 (6): 546–560. https://doi.org/10.1002/wer.1060.
Gerrity, D., B. Pecson, R. S. Trussell, and R. R. Trussell. 2013. “Potable reuse treatment trains throughout the world.” J. Water Supply Res. Technol. AQUA. 62 (6): 321–338. https://doi.org/10.2166/aqua.2013.041.
Hai, F. I., T. Riley, S. Shawkat, S. F. Magram, and K. Yamamoto. 2014. “Removal of pathogens by membrane bioreactors: A review of the mechanisms, influencing factors and reduction in chemical disinfectant dosing.” Water. 6 (12): 3603–3630. https://doi.org/10.3390/w6123603.
Hamza, I. A., L. Jurzik, K. Überla, and M. Wilhelm. 2011. “Evaluation of pepper mild mottle virus, human picobirnavirus and Torque teno virus as indicators of fecal contamination in river water.” Water Res. 45 (3): 1358–1368. https://doi.org/10.1016/j.watres.2010.10.021.
Haramoto, E., M. Kitajima, N. Kishida, Y. Konno, H. Katayama, M. Asami, and M. Akiba. 2013. “Occurrence of pepper mild mottle virus in drinking water sources in Japan.” Appl. Environ. Microbiol. 79 (23): 7413–7418. https://doi.org/10.1128/AEM.02354-13.
Hill, V. R., A. L. Polaczyk, D. Hahn, J. Narayanan, T. L. Cromeans, J. M. Roberts, and J. E. Amburgey. 2005. “Development of a rapid method for simultaneous recovery of diverse microbes in drinking water by ultrafiltration with sodium polyphosphate and surfactants.” Appl. Environ. Microbiol. 71 (11): 6878–6884. https://doi.org/10.1128/AEM.71.11.6878-6884.2005.
Hirani, Z. M., Z. Bukhari, J. Oppenheimer, P. Jjemba, M. W. LeChevallier, and J. G. Jacangelo. 2014. “Impact of MBR cleaning and breaching on passage of selected microorganisms and subsequent inactivation by free chlorine.” Water Res. 57 (Jun): 313–324. https://doi.org/10.1016/j.watres.2014.03.038.
Hmaied, F., S. Keskes, S. Jebri, I. Amri, M. Yahya, F. Loisy-Hamon, B. Lebeau, and M. Hamdi. 2015. “Removal of rotavirus and bacteriophages by membrane bioreactor technology from sewage.” Curr. Microbiol. 71 (5): 540–545. https://doi.org/10.1007/s00284-015-0882-y.
Howell, J. A., and B. Atkinson. 1976. “Sloughing of microbial film in trickling filters.” Water Res. 10 (4): 307–315. https://doi.org/10.1016/0043-1354(76)90172-X.
Jofre, J., A. R. Blanch, F. Lucena, and M. Muniesa. 2014. “Bacteriophages infecting Bacteroides as a marker for microbial source tracking.” Water Res. 55 (May): 1–11. https://doi.org/10.1016/j.watres.2014.02.006.
Jumat, M. R., N. A. Hasan, P. Subramanian, C. Heberling, R. R. Colwell, and P. Y. Hong. 2017. “Membrane bioreactor-based wastewater treatment plant in Saudi Arabia: Reduction of viral diversity, load, and infectious capacity.” Water. 9 (7): 534. https://doi.org/10.3390/w9070534.
Kato, R., T. Asami, E. Utagawa, and H. Furumai. 2018. “Pepper mild mottle virus as a process indicator at drinking water treatment plants employing coagulation-sedimentation, rapid sand filtration, ozonation, and biological activated carbon treatments in Japan.” Water Res. 132 (Apr): 61–70. https://doi.org/10.1016/j.watres.2017.12.068.
Kim, T., and H. Unno. 1996. “The roles of microbes in the removal and inactivation of viruses in a biological wastewater treatment system.” Water Sci. Technol. 33 (10–11): 243–250. https://doi.org/10.2166/wst.1996.0681.
Kummu, M., P. J. Ward, H. De Moel, and O. Varis. 2010. “Is physical water scarcity a new phenomenon? Global assessment of water shortage over the last two millennia.” Environ. Res. Lett. 5 (3): 034006. https://doi.org/10.1088/1748-9326/5/3/034006.
Kuo, D., F. J. Simmons, S. Blair, E. Hart, J. B. Rose, and I. Xagoraraki. 2010. “Assessment of human adenovirus removal in a full-scale membrane bioreactor treating municipal wastewater.” Water Res. 44 (5): 1520–1530. https://doi.org/10.1016/j.watres.2009.10.039.
Layton, A., L. McKay, D. Williams, V. Garrett, R. Gentry, and G. Sayler. 2006. “Development of Bacteroides 16S rRNA gene Taqman-based real-time PCR assays for estimation of total, human, and bovine fecal pollution in water.” Appl. Environ. Microbiol. 72 (6): 4214–4224. https://doi.org/10.1128/AEM.01036-05.
Ley, R. E., D. A. Peterson, and J. I. Gordon. 2006. “Ecological and evolutionary forces shaping microbial diversity in the human intestine.” Cell. 124 (4): 837–848. https://doi.org/10.1016/j.cell.2006.02.017.
Lv, W., X. Zheng, M. Yang, Y. Zhang, Y. Liu, and J. Liu. 2006. “Virus removal performance and mechanism of a submerged membrane bioreactor.” Process Biochem. 41 (2): 299–304. https://doi.org/10.1016/j.procbio.2005.06.005.
Marti, E., H. Monclús, J. Jofre, I. Rodriguez-Roda, J. Comas, and J. L. Balcázar. 2011. “Removal of microbial indicators from municipal wastewater by a membrane bioreactor (MBR).” Bioresour. Technol. 102 (8): 5004–5009. https://doi.org/10.1016/j.biortech.2011.01.068.
Miura, T., S. Okabe, Y. Nakahara, and D. Sano. 2015. “Removal properties of human enteric viruses in a pilot-scale membrane bioreactor (MBR) process.” Water Res. 75 (May): 282–291. https://doi.org/10.1016/j.watres.2015.02.046.
Mühl, H., A. J. Kochem, C. Disqué, and S. G. Sakka. 2010. “Activity and DNA contamination of commercial polymerase chain reaction reagents for the universal 16S rDNA real-time polymerase chain reaction detection of bacterial pathogens in blood.” Diagn. Microbiol. Infect. Dis. 66 (1): 41–49. https://doi.org/10.1016/j.diagmicrobio.2008.07.011.
Newton, R. J., S. L. McLellan, D. K. Dila, J. H. Vineis, H. G. Morrison, A. M. Eren, and M. L. Sogin. 2015. “Sewage reflects the microbiomes of human populations.” MBio. 6 (2): e02574–14. https://doi.org/10.1128/mBio.02574-14.
Nielsen, K. M., P. J. Johnsen, D. Bensasson, and D. Daffonchio. 2007. “Release and persistence of extracellular DNA in the environment.” Environ. Biosaf. Res. 6 (1–2): 37–53. https://doi.org/10.1051/ebr:2007031.
Ogilvie, L. A., J. Caplin, C. Dedi, D. Diston, E. Cheek, L. Bowler, H. Taylor, J. Ebdon, and B. V. Jones. 2012. “Comparative (meta)genomic analysis and ecological profiling of human gut-specific bacteriophage ϕB124-14.” PLoS One. 7 (4): e35053. https://doi.org/10.1371/journal.pone.0035053.
Oki, T., and S. Kanae. 2006. “Global hydrological cycles and world water resources.” Science. 313 (5790): 1068–1072. https://doi.org/10.1126/science.1128845.
Ottoson, J., A. Hansen, B. Björlenius, H. Norder, and T. A. Stenström. 2006. “Removal of viruses, parasitic protozoa and microbial indicators in conventional and membrane processes in a wastewater pilot plant.” Water Res. 40 (7): 1449–1457. https://doi.org/10.1016/j.watres.2006.01.039.
Paranychianakis, N. V., M. Salgot, S. A. Snyder, and A. N. Angelakis. 2015. “Water reuse in EU states: Necessity for uniform criteria to mitigate human and environmental risks.” Crit. Rev. Environ. Sci. Technol. 45 (13): 1409–1468. https://doi.org/10.1080/10643389.2014.955629.
Pecson, B. M., E. C. Chen, S. C. Triolo, A. N. Pisarenko, S. Olivieri, E. Idica, A. Kolakovsky, R. S. Trussell, and R. R. Trussell. 2018. “Mechanical reliability in potable reuse: Evaluation of an advanced water purification facility.” J. Am. Water Works Assoc. 110 (4): E19–E28. https://doi.org/10.1002/awwa.1045.
Pecson, B. M., R. S. Trussell, A. N. Pisarenko, and R. R. Trussell. 2015. “Achieving reliability in potable reuse: The four Rs.” J. Am. Water Works Assoc. 107 (3): 48–58. https://doi.org/10.5942/jawwa.2015.107.0047.
Purnell, S., J. Ebdon, A. Buck, M. Tupper, and H. Taylor. 2016. “Removal of phages and viral pathogens in a full-scale MBR: Implications for wastewater reuse and potable water.” Water Res. 100 (Sep): 20–27. https://doi.org/10.1016/j.watres.2016.05.013.
Rand, K. H., and H. Houck. 1990. “Taq polymerase contains bacterial DNA of unknown origin.” Mol. Cell. Probes. 4 (6): 445–450. https://doi.org/10.1016/0890-8508(90)90003-I.
Reischer, G. H., et al. 2013. “Performance characteristics of qPCR assays targeting human- and ruminant-associated Bacteroidetes for microbial source tracking across sixteen countries on six continents.” Environ. Sci. Technol. 47 (15): 8548–8556. https://doi.org/10.1021/es304367t.
Rhodes, E. R., E. M. Huff, D. W. Hamilton, and J. L. Jones. 2016. “The evaluation of hollow-fiber ultrafiltration and celite concentration of enteroviruses, adenoviruses and bacteriophage from different water matrices.” J. Virol. Methods. 228 (Feb): 31–38. https://doi.org/10.1016/j.jviromet.2015.11.003.
Rosario, K., E. M. Symonds, C. Sinigalliano, J. Stewart, and M. Breitbart. 2009. “Pepper mild mottle virus as an indicator of fecal pollution.” Appl. Environ. Microbiol. 75 (22): 7261–7267. https://doi.org/10.1128/AEM.00410-09.
Rueckert, A., and H. W. Morgan. 2007. “Removal of contaminating DNA from polymerase chain reaction using ethidium monoazide.” J. Microbiol. Methods. 68 (3): 596–600. https://doi.org/10.1016/j.mimet.2006.11.006.
Salter, S. J., M. J. Cox, E. M. Turek, S. T. Calus, W. O. Cookson, M. F. Moffatt, P. Turner, J. Parkhill, N. J. Loman, and A. W. Walker. 2014. “Reagent and laboratory contamination can critically impact sequence-based microbiome analyses.” BMC Biol. 12 (1): 1–12. https://doi.org/10.1186/s12915-014-0087-z.
Sano, D., M. Amarasiri, A. Hata, T. Watanabe, and H. Katayama. 2016. “Risk management of viral infectious diseases in wastewater reclamation and reuse: Review.” Environ. Int. 91 (May): 220–229. https://doi.org/10.1016/j.envint.2016.03.001.
Schimmoller, L. J., M. J. Kealy, and S. K. Foster. 2015. “Triple bottom line costs for multiple potable reuse treatment schemes.” Environ. Sci. Water Res. Technol. 1 (5): 644–658. https://doi.org/10.1039/C5EW00044K.
Shirasaki, N., T. Matsushita, Y. Matsui, and K. Murai. 2017. “Assessment of the efficacy of membrane filtration processes to remove human enteric viruses and the suitability of bacteriophages and a plant virus as surrogates for those viruses.” Water Res. 115 (May): 29–39. https://doi.org/10.1016/j.watres.2017.02.054.
Shkoporov, A. N., E. V. Khokhlova, C. B. Fitzgerald, S. R. Stockdale, L. A. Draper, R. P. Ross, and C. Hill. 2018. “ΦCrAss001represents the most abundant bacteriophage family in the human gut and infects Bacteroides intestinalis.” Nat. Commun. 9 (Nov): 4781. https://doi.org/10.1038/s41467-018-07225-7.
Simmons, F. J., D. H. Kuo, and I. Xagoraraki. 2011. “Removal of human enteric viruses by a full-scale membrane bioreactor during municipal wastewater processing.” Water Res. 45 (9): 2739–2750. https://doi.org/10.1016/j.watres.2011.02.001.
Smith, C. M., and V. R. Hill. 2009. “Dead-end hollow-fiber ultrafiltration for recovery of diverse microbes from water.” Appl. Environ. Microbiol. 75 (16): 5284–5289. https://doi.org/10.1128/AEM.00456-09.
Spangler, R., N. L. Goddard, and D. S. Thaler. 2009. “Optimizing Taq polymerase concentration for improved signal-to-noise in the broad range detection of low abundance bacteria.” PLoS One. 4 (9): e7010. https://doi.org/10.1371/journal.pone.0007010.
Stachler, E., A. Benay, N. A. de Carvalho, C. Ference, and K. Bibby. 2018. “Correlation of crAssphage qPCR markers with culturable and molecular indicators of human fecal pollution in an impacted urban watershed.” Environ. Sci. Technol. 52 (13): 7505–7512. https://doi.org/10.1021/acs.est.8b00638.
Stachler, E., and K. Bibby. 2014. “Metagenomic evaluation of the highly abundant human gut bacteriophage crAssphage for source tracking of human fecal pollution.” Environ. Sci. Technol. Lett. 1 (10): 405–409. https://doi.org/10.1021/ez500266s.
Stachler, E., C. Kelty, M. Sivaganesan, X. Li, K. Bibby, and O. C. Shanks. 2017. “Quantitative crAssphage PCR assays for human fecal pollution measurement.” Environ. Sci. Technol. 51 (16): 9146–9154. https://doi.org/10.1021/acs.est.7b02703.
Stamps, B. W., M. B. Leddy, M. H. Plumlee, N. A. Hasan, R. R. Colwell, and J. R. Spear. 2018. “Characterization of the microbiome at the world’s largest potable water reuse facility.” Front. Microbiol. 9 (Oct): 2435. https://doi.org/10.3389/fmicb.2018.02435.
SWRCB (California State Water Resources Control Board). 2016. Evaluation of the feasibility of developing uniform water recycling criteria for direct potable reuse. Sacramento, CA: SWRCB.
Symonds, E. M., K. H. Nguyen, V. J. Harwood, and M. Breitbart. 2018. “Pepper mild mottle virus: A plant pathogen with a greater purpose in (waste)water treatment development and public health management.” Water Res. 144 (Nov): 1–12. https://doi.org/10.1016/j.watres.2018.06.066.
Tackaert, R. A., A. N. Pisarenko, E. C. Chen, A. Kolakovsky, B. M. Pecson, J. E. Drewes, R. R. Trussell, and R. S. Trussell. 2019. “Demonstrating process robustness of potable reuse treatment trains during challenge testing with elevated levels of acetone, formaldehyde, NDMA, and 1,4-dioxane.” J. Water Supply Res. Technol. AQUA 68 (5): 313–324. https://doi.org/10.2166/aqua.2019.134.
Tondeur, S., O. Agbulut, M. L. Menot, J. Larghero, D. Paulin, P. Menasche, J. L. Samuel, C. Chomienne, and B. Cassinat. 2004. “Overcoming bacterial DNA contamination in real-time PCR and RT-PCR reactions for LacZ detection in cell therapy monitoring.” Mol. Cell. Probes. 18 (6): 437–441. https://doi.org/10.1016/j.mcp.2004.08.002.
TWDB (Texas Water Development Board). 2015. Direct potable reuse resource document. Austin, TX: TWDB.
Ueda, T., and N. J. Horan. 2000. “Fate of indigenous bacteriophage in a membrane bioreactor.” Water Res. 34 (7): 2151–2159. https://doi.org/10.1016/S0043-1354(99)00382-6.
USEPA. 2012. Guidelines for water reuse. Rep. No. EPA/600/R-12/618. Washington, DC: USEPA.
Van den Akker, B., T. Trinh, H. M. Coleman, R. M. Stuetz, P. Le-Clech, and S. J. Khan. 2014. “Validation of a full-scale membrane bioreactor and the impact of membrane cleaning on the removal of microbial indicators.” Bioresour. Technol. 155 (Mar): 432–437. https://doi.org/10.1016/j.biortech.2013.12.123.
Vörösmarty, C., P. Green, J. Salisbury, and R. Lammers. 2000. “Global water resources: Vulnerability from climate change and population growth.” Sci. 289 (5477): 284–288. https://doi.org/10.1126/science.289.5477.284.
Ward, R. L. 1982. “Evidence that microorganisms cause inactivation of viruses in activated sludge.” Appl. Environ. Microbiol. 43 (5): 1221–1224.
Wetter, C., M. Conti, D. Altschuh, R. Tabillion, and M. H. V. van Regenmortel. 1984. “Pepper mild mottle virus, a Tobamovirus infecting pepper cultivars in Sicily.” Etiology 74 (4): 405–410.
WHO (World Health Organization). 2017. Potable reuse: Guidance for producing safe drinking-water. Geneva: WHO.
Wu, J., H. Li, and X. Huang. 2010. “Indigenous somatic coliphage removal from a real municipal wastewater by a submerged membrane bioreactor.” Water Res. 44 (6): 1853–1862. https://doi.org/10.1016/j.watres.2009.12.013.
Xagoraraki, I., Z. Yin, and Z. Svambayev. 2014. “Fate of viruses in water systems.” J. Environ. Eng. 140 (7): 04014020. https://doi.org/10.1061/(ASCE)EE.1943-7870.0000827.
Zanetti, F., G. De Luca, and R. Sacchetti. 2010. “Performance of a full-scale membrane bioreactor system in treating municipal wastewater for reuse purposes.” Bioresour. Technol. 101 (10): 3768–3771. https://doi.org/10.1016/j.biortech.2009.12.091.
Zhang, K., and K. Farahbakhsh. 2007. “Removal of native coliphages and coliform bacteria from municipal wastewater by various wastewater treatment processes: Implications to water reuse.” Water Res. 41 (12): 2816–2824. https://doi.org/10.1016/j.watres.2007.03.010.
Zhang, T., M. Breitbart, W. H. Lee, J. Q. Run, C. L. Wei, S. W. L. Soh, M. L. Hibberd, E. T. Liu, F. Rohwer, and Y. Ruan. 2006. “RNA viral community in human feces: Prevalence of plant pathogenic viruses.” PLoS Biol. 4 (1): 0108–0118. https://doi.org/10.1371/journal.pbio.0040003.

Information & Authors

Information

Published In

Go to Journal of Environmental Engineering
Journal of Environmental Engineering
Volume 146Issue 2February 2020

History

Received: Feb 22, 2019
Accepted: May 7, 2019
Published online: Nov 21, 2019
Published in print: Feb 1, 2020
Discussion open until: Apr 21, 2020

ASCE Technical Topics:

Authors

Affiliations

Postdoctoral Researcher, Dept. of Civil and Environmental Engineering and Construction, Univ. of Nevada Las Vegas, 4505 S. Maryland Pkwy., P.O. Box 454015, Las Vegas, NV 89154; Postdoctoral Researcher, Division of Hydrologic Sciences, Desert Research Institute, 755 E. Flamingo Rd., Las Vegas, NV 89119; Postdoctoral Researcher, Applied Research and Development Center, Southern Nevada Water Authority, P.O. Box 99954, Las Vegas, NV 89193. ORCID: https://orcid.org/0000-0001-8126-4822. Email: [email protected]; [email protected]; [email protected]
Duane Moser [email protected]
Associate Professor, Division of Hydrologic Sciences, Desert Research Institute, 755 E. Flamingo Rd., Las Vegas, NV 89119. Email: [email protected]
Associate Professor, Dept. of Civil and Environmental Engineering and Construction, Univ. of Nevada Las Vegas, 4505 S. Maryland Pkwy., P.O. Box 454015, Las Vegas, NV 89154; Principal Research Laboratory Scientist, Applied Research and Development Center, Southern Nevada Water Authority, P.O. Box 99954, Las Vegas, NV 89193 (corresponding author). ORCID: https://orcid.org/0000-0001-8019-9723. Email: [email protected]; [email protected]

Metrics & Citations

Metrics

Citations

Download citation

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

Cited by

View Options

Media

Figures

Other

Tables

Share

Share

Copy the content Link

Share with email

Email a colleague

Share